Provectus Pharmaceuticals Inc. Updates Shareholders with Year in Review and Discusses Clinical Development Plans

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, updates shareholders on its accomplishments for 2010 and what to expect in the first part of 2011.